Last updated: November 2, 2021
Sponsor: Szeged University
Overall Status: Active - Recruiting
Phase
N/A
Condition
Diabetes Prevention
High Cholesterol (Hyperlipidemia)
Metabolic Syndrome
Treatment
N/AClinical Study ID
NCT05117580
TMED_METSZI_001
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Age between 18 years and 75 years
- Presence of at least three of the following five risk factors (Metabolic Syndrome ATPIII Criteria):
- waist width above 102 cm in men and 88 cm in women
- treated diabetes or blood sugar above 5.6 mmol / l
- treated hypertension or spontaneous blood pressure ≥ 130/85 mmHg
- fibrate treatment or triglyceride levels above 1.7 mmol / l
- blood HDL cholesterol levels below 1.03 mmol / l in men and 1.3 mmol / l in women
Exclusion
Exclusion Criteria:
- Low level of physical activity (less than 30 minutes a day)
- IT proficiency at least for basic use of mobile phones (answering / making voicecalls).
- For women with childbearing potential, by definition, all women who are able toconceive physiologically use dual contraception
- Signing an informed consent.
- The subject communicates well with the investigator and is able to help understand andadhere to the requirements of the study plan.
Study Design
Total Participants: 130
Study Start date:
July 01, 2021
Estimated Completion Date:
February 28, 2022
Study Description
Connect with a study center
University of Szeged
Szeged, 6720
HungaryActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.